AIM
IDXX icon

Advantage Investment Management’s Idexx Laboratories IDXX Stock Holding History

Advantage Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-53
Closed -$13K – 1026
2018
Q3 		$13K Buy
+53
New +$12.9K 0.01% 656

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Advantage Investment Management's IDXX Position: Q4 2018 in Review

Advantage Investment Management sold out of Idexx Laboratories (IDXX) in Q4 2018, closing a stake of 53 shares — an estimated $13K sold.

Advantage Investment Management first reported a position in IDXX in Q3 2018 and held it in 1 quarter. The position peaked at $13K in Q3 2018. 670 funds tracked by Wall St. Rank hold IDXX as of Q4 2018.

  • Advantage Investment Management reported no remaining Idexx Laboratories position as of Q4 2018 after selling out during the quarter.
  • Advantage Investment Management sold 53 Idexx Laboratories shares in Q4 2018, an estimated $13K.
  • Advantage Investment Management first reported a position in Idexx Laboratories in Q3 2018 and held it in 1 quarter.
  • Advantage Investment Management's Idexx Laboratories position peaked at $13K in Q3 2018.
  • 670 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2018.

Based on Advantage Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.